iiinova — where your digital self keeps evolving

Miriam Molina-Arcas @molinaarcas.bsky.social · 20/09/2026

Led by the talented Mona Tomaschko, this was a fantastic team effort. Very proud of the work and grateful to everyone who contributed! #Downwardlab

000 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 20/09/2026

We show that combination therapies that stimulate antitumour immunity promote the immune-mediated elimination of KRAS-G12C inhibitor-resistant subpopulations, providing a potential strategy to overcome drug resistance that may have relevance in broader therapeutic settings. #KRAS #DrugResistance

100 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 10/10/2025

🎬 #TargetingRAS2025 comes to an end! Three inspiring days of talks, round tables, and networking around the latest advances and challenges in RAS research. 🧬💡 A big thank you to all attendees, speakers, sponsors, partners, and the organizing committee for making this 2nd edition possible. 💙

011 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 09/10/2025

🎥 Day 2 of #TargetingRAS2025 comes to an end! A day filled with great talks, round tables, and outstanding speakers sharing insights on RAS research. 🧬💡 ✨ Tonight: the Symposium Dinner. 👉 Tomorrow: the final day of the symposium.

011 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 08/10/2025

🎥 Day 1 of #TargetingRAS2025 wrapped up! An inspiring start with outstanding talks, great discussions, and valuable scientific exchange on RAS research. Huge thanks to all speakers, attendees & organizers for a successful first day. ✨ Two more days to go—stay tuned!

133 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 11/08/2025

‼️ Last days to submit your abstract for Targeting RAS 2025! 📅 Deadline: August 15 🏆 2 x €250 Molecular Oncology (FEBS) poster prizes Complete your registration at 👉🏼 targetingras.com/registration and upload your abstract now! #TargetingRAS2025 #25anniversaryCIC

101 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 27/06/2025

We have spent four great days talking about Small G proteins. Thanks Angeliki Malliri, @ianprior.bsky.social @biochemsoc.bsky.social for the invitation and the organization #BiochemEvent #SGP25

150 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 15/06/2025

It was great to see everybody so engaged with the scientific discussions. Even more than with the pool and table football matches #Downwardlab

030 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 13/05/2025

(1/4) 🔗 Science thrives on connections! 🗨️ At the Targeting RAS Symposium 2025, networking opportunities are an essential part of the experience. The programme has been designed in order to propitiate the exchange of ideas between young talent and established researchers.

102 0

Reposted by Miriam Molina-Arcas

American Association for Cancer Research (AACR) @theaacr.bsky.social · 28/04/2025

At yesterday's opening ceremony, we asked the cancer community to stand together to make their voices heard in support of innovative cancer science and medicine. #CancerResearchSavesLives® #AACR25

15025 0

Reposted by Miriam Molina-Arcas

Ian Prior @ianprior.bsky.social · 22/04/2025

Final week for the early bird deadline for the Small G-protein meeting in Manchester. Talk slots available from submitted abstracts. #SGP25 @BiochemSoc @SmallGTPases Register here: bit.ly/SmallG25

bit.ly

Small G proteins in cellular signalling and disease 2025

046 0

Reposted by Miriam Molina-Arcas

Targeting RAS @targetingras.bsky.social · 04/04/2025

1/5 🔬 Meet the Organizing Committee for the Targeting RAS Symposium 2025! A distinguished Organizing Committee of leading researchers and experts is shaping an event dedicated to cutting-edge advances in RAS-driven cancers. #TargetingRAS2025

133 0

Reposted by Miriam Molina-Arcas

Dr Colin Lindsay @drcolinlindsay.bsky.social · 27/03/2025

1) KRYSTAL-7 update on pembro+adagrasib in 1st line pdl1 >50% nsclc. Tox to navigate but mPFS >27m! Further reinforcing the view that ras orchestrates TME, not just cancer cell intrinsic pathways. Massive congrats to investigators, mirati, bms #ELCC25

065 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 14/02/2025

For RAS enthusiasts, register to the 2nd Targeting RAS symposium! Amazing speakers in beautiful Salamanca #RAS #KRAS

011 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 12/02/2025

It was a pleasure to speak at the EACR-Boehringer Ingelheim Conference on Drugging and Regulating the MAP Kinase Pathway. Thanks a lot to the organisers for these two days of exciting science @helloeacr.bsky.social

091 0

Reposted by Miriam Molina-Arcas

Francesca Ciccarelli @ciccarellilab.bsky.social · 25/01/2025

With Ilaria Malanchi @ila07.bsky.social we will host the #MedicineattheCrick event (13th March at the Crick @crick.ac.uk.) Join world experts to discuss how early mutant cells interact with surrounding niche to maintain homeostasis or start cancer. Free registration! Details in the poster 👇

0258 0

Miriam Molina-Arcas @molinaarcas.bsky.social · 15/12/2024

Thanks @iaslc.bsky.social for the invitation to speak at this amazing meeting. Hot Topic Meeting: Tolerance and #Resistance to #TargetedTherapy in #NSCLC. Incredible talks and discussions. #HTTR2024 www.httr2024-iaslc.org/full-program

httr2024-iaslc.org

Full Program - HTTR24 - Hilton DC National Mall The Wharf

000 0

Reposted by Miriam Molina-Arcas

Anna Obenauf @obenaufa.bsky.social · 22/11/2024

Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research! Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway" organised with @EACRnews with @Boehringer eacr.org/conference/boe…

eacr.org

12012 0